Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04652713
Other study ID # P11-GoDag
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 24, 2020
Est. completion date November 21, 2023

Study information

Verified date May 2024
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigators will in a crossover study test the health effects of eating a dairy-based protein-rich breakfast, isocaloric carbohydrate-rich breakfast or no breakfast in young overweight women. Determination of satiety and hunger using visual analog scores (VAS), collection of blood samples and 2x 24 hours food logs will be collected.


Description:

This study is a single-blind randomized Cross-Over trial with 30 women aged 18-30 years, each completing three trials. Participants will consume either dairy-based protein-rich breakfast, isocaloric, fiber matched, fat matched, carbohydrate-rich breakfast or no breakfast in randomized order. Three hours later a standardized ad libitum lunch will be served. Blood samples will be collected (pre, 10 min, 30 min, 60 min, 120 min, 175 min after breakfast) and VAS rating hunger, satiety and desire to eat will be determined (pre, during breakfast, 10, 30, 60, 90, 120, 180 min, during lunch, after lunch). Twenty-four hour food logs on the day before the test day and on the test day will be collected. Participants will be characterized by determining height (cm), weight (kg), and body composition by a dual-energy X-ray (DXA) scan before the first test day.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date November 21, 2023
Est. primary completion date September 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Body mass index > 25 - Age 18-25 years - Regular exercise < 5 hour per week Exclusion Criteria: - illness and use of medication affecting the study outcomes - allergy towards lactose or gluten - weightloss/gain >5kg the last 6 months - dieting - eating disorder - pregnancy - breast feeding - unable to speak and understand danish

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Protein-rich breakfast
High protein yoghurt containing approx. 10 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) yoghurt with 40 g oats for breakfast. 1 glas of water (150 ml)
Carbohydrate-rich breakfast
Low protein breakfast containing approx. 2 g protein per 100 g. Participants will be asked to consume ~60 g bread, 20 g jam and 250 ml juice for breakfast. 1 glas of water (150 ml)
No breakfast
1 glas of water (150 ml)

Locations

Country Name City State
Denmark Aarhus University, Department for Public Health, Section for Sport Science Aarhus

Sponsors (2)

Lead Sponsor Collaborator
University of Aarhus The Danish Dairy Research Foundation, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Height Height in cm Baseline
Other Weight Weight in kg Baseline
Other Body composition fat DXA-scanning to determine fat mass Baseline
Other Body composition fat free DXA-scanning to determine fat free mass Baseline
Primary Energy consumption on test days Total energy consumption on test days (24 hour food log) 0-24 hours
Secondary Change in hunger Visual Analog Scale (10 cm) score for feeling of hunger 0-3 hours
Secondary Change in satiety Visual Analog Scale (10 cm) score for feeling of satiety 0-3 hours
Secondary change in desire Visual Analog Scale (10 cm) score for feeling of desire to eat 0-3 hours
Secondary Change in ghrelin in blood sample 0-3 hours
Secondary Change in leptin in blood sample 0-3 hours
Secondary Change in glucose-dependent insulinotropic polypeptide (GIP) in blood sample 0-3 hours
Secondary Change in Peptide YY (PYY3-36) in blood sample 0-3 hours
Secondary Change in insulin in blood sample 0-3 hours
Secondary Change in glucagon in blood sample 0-3 hours
Secondary Change in glucose in blood sample 0-3 hours
Secondary Energy consumption the day before a test day (food registration) Total energy consumption on the day before the test day 0-24 hours
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2